<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">AAPS PharmSciTech</journal-id><journal-id journal-id-type="iso-abbrev">AAPS PharmSciTech</journal-id><journal-id journal-id-type="pmc-domain-id">793</journal-id><journal-id journal-id-type="pmc-domain">aapspharm</journal-id><journal-title-group><journal-title>AAPS PharmSciTech</journal-title></journal-title-group><issn pub-type="epub">1530-9932</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2628257</article-id><article-id pub-id-type="pmcid-ver">PMC2628257.1</article-id><article-id pub-id-type="pmcaid">2628257</article-id><article-id pub-id-type="pmcaiid">2628257</article-id><article-id pub-id-type="pmid">19082740</article-id><article-id pub-id-type="doi">10.1208/s12249-008-9165-2</article-id><article-id pub-id-type="publisher-id">9165</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Preparation and Characterization of Salmon Calcitonin&#8211;biotin Conjugates</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Cetin</surname><given-names initials="M">Meltem</given-names></name><address><phone>+90-442-2311403</phone><fax>+90-442-2360962</fax><email>melcetin@atauni.edu.tr</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Youn</surname><given-names initials="YS">Yu Seok</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Capan</surname><given-names initials="Y">Yilmaz</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="KC">Kang Choon</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><aff id="Aff1"><label/>Department of Pharmaceutical Technology, Faculty of Pharmacy, Ataturk University, 25240 Erzurum, Turkey </aff><aff id="Aff2"><label/>Drug Targeting Laboratory, College of Pharmacy, SungKyunKwan University, 300 Chonchon-dong, Jangan-ku, Suwon City, 440-746 Republic of Korea </aff><aff id="Aff3"><label/>Faculty of Pharmacy, Department of Pharmaceutical Technology, Hacettepe University, 06100 Ankara, Turkey </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>12</month><year>2008</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2008</year></pub-date><volume>9</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">175702</issue-id><fpage>1191</fpage><lpage>1197</lpage><history><date date-type="received"><day>8</day><month>5</month><year>2008</year></date><date date-type="accepted"><day>2</day><month>11</month><year>2008</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>12</month><year>2009</year></date></event><event event-type="pmc-live"><date><day>08</day><month>11</month><year>2010</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2016-04-20 15:06:35.360"><day>20</day><month>04</month><year>2016</year></date></event></pub-history><permissions><copyright-statement>&#169; American Association of Pharmaceutical Scientists 2008</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12249_2008_Article_9165.pdf"/><abstract id="Abs1"><p>This study was performed to prepare and characterize the biotinylated Salmon calcitonin (sCT) for oral delivery and evaluate the hypocalcemic effect of biotinylated-sCTs in rats. Biotinylated sCTs was characterized by using high performance liquid chromatography (HPLC) and MALDITOF-MS. The effect of biotinylation on permeability across Caco-2 cell monolayers was examined. Their hypocalcemic effect was determined in rats. Mono- and di-bio-sCTs were separated by reverse phase HPLC. The molecular weights of mono-bio-sCT and di-bio-sCT were determined to be 3,660.5 and 3,900.2&#160;Da, respectively. The permeability of biotinylated-sCTs across Caco-2 cell monolayers was observed with a significant enhancement compared with sCT. Intrajejunal (ij) administration of mono-bio-sCT and di-bio-sCT resulted in sustained reduction in serum calcium levels, with a maximum reduction (% max(d)) of 21.6% and 30% after 4&#160;h and 6&#160;h of application, respectively. The biotin conjugation of sCT may be a promising strategy for increasing the oral bioavailability of sCT and achieving sustained calcium-lowering effects.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>biotinylation</kwd><kwd>Caco-2</kwd><kwd>MALDITOF-MS</kwd><kwd>oral delivery</kwd><kwd>salmon calcitonin</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; American Association of Pharmaceutical Scientists 2008</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>